Source map — Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| The Guardian | news | 60% |
| Scientific American | news | 60% |
| Eli Lilly | news | 60% |
| Reuters | news | 60% |
| WSJ | news | 60% |
| CNBC | news | 60% |
| BioPharma Dive | news | 60% |
| ScienceAlert | news | 60% |
| Medscape | news | 60% |
| Simply Wall Street | news | 60% |
| www.biospace.com | news | 50% |
| onthepen.substack.com | news | 50% |
| www.thebionews.net | news | 50% |
| peptidedosages.com | news | 50% |
| www.kalios.health | news | 50% |
| remyresearch.com | news | 50% |
| www.onedayadvisor.com | news | 50% |
| pharmaphorum.com | news | 50% |
| onthepen.com | news | 50% |
| www.europesays.com | news | 50% |
| www.archyde.com | news | 50% |
| www.biotech-now.co.uk | news | 50% |
| patientdaily.com | news | 50% |
| www.timeslive.co.za | news | 50% |
| pacifictribune.com | news | 50% |
| www.clinicalnutritioncenter.com | news | 50% |
| www.medicalnewstoday.com | news | 50% |
| omniatelehealth.com | news | 50% |
| sugarisadrug.com | news | 50% |
| dispatchtimes.com | news | 50% |
| dictionary.cambridge.org | news | 50% |
| www.vocabulary.com | news | 50% |
| usdictionary.com | news | 50% |
| www.youtube.com | news | 50% |
| www.cnbc.com | news | 50% |
| www.fool.com | news | 50% |
| longbridge.com | news | 50% |
| biotech-insider.com | news | 50% |
| www.lqventures.com | news | 50% |
| medicalxpress.com | news | 50% |
| rocketnews.com | news | 50% |
| www.beinghealthy.news | news | 50% |
| www.glp1authority.com | news | 50% |
| www.onedaymd.com | news | 50% |
| finance.yahoo.com | news | 50% |
| business-gurus.com | news | 50% |
| glpobesitymindset.substack.com | news | 50% |